🔗 Share this article

An underground economy for unlicensed weight-loss medications is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on Telegram, where communities with thousands of members share comparison photos, injection guides and assertions of next-day UK delivery. Vendors promote the substance there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, doctors and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of uncertain source.

Several experts said the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still violate pharmaceutical, marketing, and customer laws, potentially leading to penalties, legal action or prison.

Service Reaction and Content Removal

Based on TikTok, the platform has removed problematic material and banned related keywords and query recommendations. The organization said it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Trading Operations

Research also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, populated with photos of weight loss, positive reviews and detailed instructions for preparing or administering at home.

Within minutes of joining one group, a vendor shared contact information, where the majority of purchases occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Item Details and Pricing

Within these communities, messages show dark colored packages with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens typically priced at £160 for 20mg. When asked how long a pen should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram said it actively moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting substances they cannot confirm. Even if the science behind retatrutide is valid, these digital versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously encountered patients harmed by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational product not yet approved … may subject users to possibly significant health risks”.